Dementia diagnosis support software received regulatory approval. Splink supports doctors in quantifying brain atrophy
Source : "認知症診断支援ソフトの薬事認証を取得 Splink社 脳萎縮の定量化・数値化で医師をサポート" issued on ME Journal June 28th.
Splink, Inc. (“Splink”), a Japanese startup that provides medical AI (Artificial Intelligence) in the area of the central nervous system, recently received regulatory approval for its brain image analysis program “Braineer”. In light of the U.S. FDA's approval of a drug for the treatment of Alzheimer's disease, Splink expects that "early detection and accurate diagnosis will become increasingly important," and...
(Continued to the next page)
A Series of Articles
No information is found.